
The researches of tumor markers started at the discovery of Bence Jones protein in 1848. Now, alpha-fetoprotein and carcinoembryonic antigen are popular tumor markers and recently several tumor markers using the methods of monoclonal antibodies have been invented. Usually we measure the tumor markers in sera, so the early diagnosis of cancer by the tumor markers are sometimes difficult. For the early diagnosis by tumor markers, inventions of new tumor markers, improvement of assay systems and materials and the combination assays of several tumor markers have been tried. The researches of tumor markers are progressing with those of cancer. We hope we will be able to diagnose early cancer or precancerous state by tumor markers.
Adult, Male, Liver Neoplasms, Antibodies, Monoclonal, Middle Aged, Carcinoembryonic Antigen, Isoenzymes, Neoplasms, Biomarkers, Tumor, Humans, Antigens, Tumor-Associated, Carbohydrate, Female, Serologic Tests, alpha-Fetoproteins, Aged
Adult, Male, Liver Neoplasms, Antibodies, Monoclonal, Middle Aged, Carcinoembryonic Antigen, Isoenzymes, Neoplasms, Biomarkers, Tumor, Humans, Antigens, Tumor-Associated, Carbohydrate, Female, Serologic Tests, alpha-Fetoproteins, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
